Recent advances in breast cancer cell line research.

Recent advances in breast cancer cell line research.

Publication date: Jan 17, 2024

Breast cancer, a formidable global health challenge, needs continuous translational research to understand the complexity of mechanisms and improve therapeutic and diagnostic strategies. Breast cancer cell lines are of paramount importance as they significantly contribute to the initial stage of research to understand cancer biology. This review provides insights into targeted therapies and immunotherapies that have emerged using in vitro models and microbiome analysis. It focuses on therapeutic development using cell lines and the limitations of tumor heterogeneity and microenvironment. We explore the evolving landscape of breast cancer cell lines from two-dimensional (2-D) cultures to patient-derived xenograft (PDX) models advancing both fundamental and translational research. Patient-derived xenografts, cell line-derived xenografts (CDX), three-dimensional (3-D) cultures, organoids, and circulating tumor cells (CTC) models provide promising alternatives that capture the intricacies of the tumor microenvironment. This review bridges the gap between traditional cell lines and newer developments exploring the therapeutic and diagnostic advancements and needs for cell lines to expedite the progress in breast cancer research and treatment.

Concepts Keywords
Advancing breast cancer
Biology cell cultures
Cancer cell line development
Microenvironment therapeutics
Xenografts xenografts


Type Source Name
disease MESH breast cancer
pathway KEGG Breast cancer
disease IDO cell
disease MESH cancer
drug DRUGBANK Pralatrexate
drug DRUGBANK Cefadroxil
disease MESH circulating tumor cells
disease VO Gap

Original Article

(Visited 1 times, 1 visits today)